Results 161 to 170 of about 11,478,693 (361)

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

Molecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti, Giovanni Germano, Pietro Paolo Vitiello, Alberto Bardelli   +3 more
wiley   +1 more source

BAN Score and Distinct Early Cardiometabolic Risk Signatures in a Non-Diabetic Population: A Cross-Sectional Analysis [PDF]

Yazeed Alshuweishi, Noha A. Alshuwayer, Lama Izziddeen, Arwa Abudawood, Dalal Alfayez, Ahmed Basudan   +5 more
openalex   +1 more source

Risk-assessment score for screening diabetes mellitus among Omani adults [PDF]

, 2013
Melba Sheila D’Souza, Anandhi Deva Amirtharaj, Ramesh Venkatesaperumal, Chandrani Isac, Samira Maroof   +4 more
openalex   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Evaluating Confidentiality Impact in Security Risk Scoring Models [PDF]

, 2016
Eli Weintraub
openalex   +1 more source

Indian diabetic risk score screening of rural adults in Tamil Nadu

, 2023
K Myl Kumaran, D. R. Vedapriya, Aravind Manoharan, A. Y. Nirupama   +3 more
openalex   +2 more sources

Combination of phenotype and polygenic risk score in breast cancer risk evaluation in the Spanish population: A case –control study [PDF]

, 2020
Juan Carlos Triviño, A Ceba, E Rubio-Solsona, D. Serra, I Sanchez-Guiu, G Ribas, R Rosa, Mariona Cabo, L Bernad, Guillermo Pita, A Gonzalez-Neira, Garikoitz Legarda, JL Diaz, A García-Vigara, A Martínez-Aspas, M Escrig, B Bermejo, P Eroles, J Ibáñez, D. Salas, Ana Julve, Aitana Cano, A Lluch, Rebeca Miñambres, Javier Benı́tez   +24 more
openalex   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

EPCO-53. TRANSCRIPTOMIC RISK SCORE STRATIFIES EARLY PROGRESSION IN GLIOBLASTOMA [PDF]

Janette Herr, Н. С. Луцик, Kaylie Cullison, Alessandro Valderrama, Jeronimo Ignacio Pissinis, Franklin Sotolongo, Michael S. Sinclair, Marcin Pilarczyk, Pearl H. Seo, Vasileios Stathias, Stephan C. Schürer, Anthony J. Griswold, Eric A. Mellon   +12 more
openalex   +1 more source